• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Healthcare·PHCI
Share

Panamera Holdings Corporation Stocks

$ 2.5Last Updated 28.07.2026

Issuer Rating

1/7
Performance

Poor

Risk

High

Recommendation

Sell

Market Cap

$ 184.72M

$ 2.5
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Panamera Holdings Corporation currently lacks substantial ongoing business activities. Historically, the company's focus was on providing management and consulting services within the healthcare sector. Looking ahead, its strategic intent is to identify and capitalize on new business ventures. These opportunities are primarily targeted within the environmental services industry, burgeoning innovative technologies, and integrated health solutions emphasizing individual choice and innovation. The firm adopted its current name, Panamera Holdings Corporation, in October 2021, having previously operated as Panamera Healthcare Corporation. Established in 2014, the company maintains its headquarters in Houston, Texas.

Company Valuation

Greatly overvalued
1/7

Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

31.07.2026 12:26

The Rich Spend, Too: The Whims, Grievances, and Passions of Wall Street Legends

31.07.2026 11:47

Anthropic's AI models hacked into the systems of three organizations during testing

31.07.2026 10:45

Morning Highlights: Asian markets soared amid optimism surrounding AI, while the yen gave up its gains

31.07.2026 09:00

Ferrari Raises Annual Forecast Thanks to Demand for Limited-Edition Models

31.07.2026 03:07

Apple shares fell after a weak forecast. Sales will be affected by a shortage of memory chips

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026